GL1X · GenesisL1 explorer

Research workbench

Potent, nonpeptide inhibitors of human mast cell tryptase

Analyse Potent, nonpeptide inhibitors of human mast cell tryptase in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2ZEC
Type
protein
Length
968 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tryptase beta 2
EC
3.4.21.-
UniProt
Q6B052
Ligands
11N
Pockets
8 · best druggability 0.56

Structure

x-ray diffraction · 1 distinct chain · 10% helix, 36% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, B, C, DTryptase beta 2 (EC 3.4.21.-)protein24210% helix, 36% strandQ6B052

Ligands and binding sites

  • 11N · 1-[1'-(3-phenylacryloyl)spiro[1-benzofuran-3,4'-piperidin]-5-yl]methanamine · ligand · 4 copies · chains A, C, B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

8 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13030.560.7633empty
22530.540.7631empty
3940.380.762311N
4970.350.7415empty
5720.340.762411N

Interfaces

4 interfaces between chains.

  • B–D · 1098 Ų buried · 10 hydrogen bonds · protein-protein
  • A–C · 1066 Ų buried · 12 hydrogen bonds · protein-protein
  • A–D · 454 Ų buried · 1 hydrogen bond · protein-protein
  • B–C · 449 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 16 disulfide (disulfide).

Compared structures

  • 2ZEC · Potent, Nonpeptide Inhibitors of Human Mast Cell Tryptase · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.